AI-Crafted Universal Coronavirus Vaccine Clears Phase I Trial

1 min read
Source: Gizmodo
AI-Crafted Universal Coronavirus Vaccine Clears Phase I Trial
Photo: Gizmodo
TL;DR

Researchers at Cambridge used AI to design a pan-coronavirus vaccine, pEVAC-PS, which in a Phase I trial in 39 healthy volunteers appeared safe and elicited cross-reactive immune responses to multiple sarbecoviruses; the team plans Phase II trials and has spun off DIOSynVax to commercialize the AI platform for universal vaccines against threats like flu and Ebola.

Share this article

Want the full story? Read the original reporting

Read on Gizmodo